Cite
HARVARD Citation
Morikawa, K. et al. (2020). Hypothesis generative head-to-head study comparing efficacy of afatinib and osimertinib based on immunological biomarkers in Japanese NSCLC patients with EGFR mutations (Heat on Beat study). Therapeutic advances in medical oncology. p. . [Online].